Washington 2023-2024 Regular Session

Washington House Bill HB1261

Introduced
1/12/23  
Refer
1/12/23  
Report Pass
1/20/23  
Refer
1/23/23  
Report Pass
2/10/23  

Caption

Concerning cost sharing for diagnostic and supplemental breast examinations.

Impact

The discussions surrounding HB 1261 indicate a general recognition of the importance of preventive healthcare. Proponents of the bill argue that reducing cost barriers will facilitate more women obtaining regular breast examinations, which is pivotal for early detection of breast cancer. The expectation is that this proactive approach will ultimately lead to better patient outcomes and can possibly reduce long-term healthcare costs associated with late-stage diagnoses. However, the specific adjustments to existing insurance frameworks and how these changes will be implemented remain points of interest.

Summary

House Bill 1261 focuses on cost sharing for diagnostic and supplemental breast examinations, aiming to improve access to crucial healthcare services for women. The bill intends to alleviate the financial burden associated with these procedures, which can often deter individuals from seeking necessary medical attention. By addressing cost-sharing mechanisms, the bill asserts that it will enhance healthcare access and early detection of breast-related health issues, thereby promoting overall public health in the state.

Sentiment

The sentiment around HB 1261 seems largely positive, particularly among health advocacy groups and those within the healthcare sector who champion women's health issues. Lawmakers supporting the bill express a commitment to addressing healthcare inequality, emphasizing that this legislation is a step forward in ensuring that women are not deterred from critical screenings due to financial reasons. Nonetheless, there are concerns from insurance providers about the potential economic implications of mandated changes in cost-sharing policies.

Contention

While generally supported, some contention exists regarding how this bill will interact with existing health insurance regulations. Opponents have raised questions about the bill's implementation, particularly its financial ramifications on insurance companies and policyholders alike. There are fears that the changes may lead to increased insurance premiums or reallocation of funds from other essential services. As legislators weigh these considerations, the discussions reveal an ongoing dialogue about balancing cost management in healthcare with the need to provide accessible preventative services.

Companion Bills

No companion bills found.

Previously Filed As

WA SB5396

Concerning cost sharing for diagnostic and supplemental breast examinations.

WA H0773

Coverage for Diagnostic and Supplemental Breast Examinations

WA H0575

Coverage for Diagnostic and Supplemental Breast Examinations

WA H0141

State Group Insurance Program Coverage for Diagnostic and Supplemental Breast Examinations

WA HB376

Health Insurance - Diagnostic and Supplemental Examinations and Biopsies for Breast Cancer - Cost-Sharing

WA SB184

Health Insurance - Diagnostic and Supplemental Examinations and Biopsies for Breast Cancer - Cost-Sharing

WA S0158

Coverage for Diagnostic and Supplemental Breast Examinations

WA SB5075

Concerning cost sharing for prenatal and postnatal care.

WA HB5618

Relating to cost sharing for diagnostic and supplemental breast examinations

WA HB3339

Relating to cost sharing for diagnostic and supplemental breast examinations

Similar Bills

No similar bills found.